Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunomodulatory Effect of Paravertebral Block and TIVA in Spine Surgery
NCT03437213Completed
- Start
- Jan 2018
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of bupivacaine hydrochloride 0.75% injection in pain (2 arms). Primary endpoints: Serum levels of interleukin 6 and Serum levels of interleukin 1beta. Started Jan 2018; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
pain
Beyond the preview
Go deeper on NCT03437213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03437213.